Hambrecht M. Führen Alkohol und Drogenmissbrauch zur Schizophrenie? [Do alcohol or drug abuse induce schizophrenia?] / M. Hambrecht, H. Häfner // Nervenarzt.- 1996.- Bd.67.- S.36-45.
Hambrecht M. Fuhren Alkohol-oder Drogenmissbrauch zu Schizophrenie? / M. Hambrecht, H. Hafner // Nervenarzt. - 1996. – Bd.67,№1. – S.36-45.
Hambrecht M. Substance abuse and the onset of schizophrenia / M. Hambrecht, H. Häfner // Biol Psychiatry.- 1996.- Vol.40.- P.1155–1163.
Hasin D.S. Comorbidity of alcohol, drug, and psychiatric disorders: epidemiology / D.S. Hasin, E.V. Nunes // Dual Diagnosis and Treatment: Substance Abuse and Psychiatric Disorders / eds.: H.R. Kranzler, B.J. Rounsaville.- New York, NY: Marcel Decker Inc, 1988.
Hendin H. Suiside: A review of directions in research / H. Hendin // Hosp. commun. Psychiatry.- 1986.- Vol.37,№2.- P.148-154.
Khantzian E.J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications / E.J. Khantzian // Harv Rev Psychiatry.- 1997.- Vol.4.- P.231–244.
Konsummuster und Konsummotivation des Suchtmittelgebrauchs bei schizophrenen Patienten / M. Lambert [et al.] // Psychiatr-Prax. – 1997. – Bd. 24, № 4. – S.185-194.
Lambert T.J. Medical comorbidity in schizophrenia / T.J. Lambert D. Velakoulis, C. Pantelis // Med. J. Aust. – 2003. – Bd.178. – S.67-70.
Lenzenweger M.F. The Longitudinal Study of Personality Disorders: Hystory, Design Considerations, and Initial Fingings / M.F. Lenzenweger // J. of Personality Disorders.- 2006.- Vol.20,№6.- P.645-670.
Levy J.C. Suicidality, depression, and substance abuse in adolescence / J.C. Levy, E.Y. Deykin // Am J Psychiatry.- 1989.- Vol.146.- P.1462-1467.
Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey / R.C. Kessler [et al.] // Arch Gen Psychiatry.- 1997.- Vol.54.- P.313-321.
Linszen D. Cannabis abuse and the course of recent-onset schizophrenic disorders / D. Linszen, P. Dingemans, M. Lenior // Arch Gen Psychiatry.- 1994.- Vol.51.- P.273–279.
Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity / G. Rubio [et al.] // Can J Psychiatry.- 2006.- Vol.51.- P.531–538.
Masterson J.F. Counter transference and Psychotherapeutic Technique: Teaching Seminars on Psychotherapy of the Borderline Adult / J.F.-Masterson.- N.Y.: Brunner/mazel, Pub., 1983.- 305 p.
Meloy J.R. The Psychopathic Mind / J.R. Meloy - Northvale, NJ: Aronson,1988.- 324 p.
Milon T. Personality Guided Therapy / T. Milon.- London: J. Wiley, 1999.-776 p.
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene environment interaction / A. Caspi [et al.] // Biol Psychiatry.- 2005.- Vol.57.- P.1117–1127.
Mueser K. Dual diagnosis: a review of etiological theories / K. Mueser // Addict Behav.- 1998.- Vol.23.- P.717–734.
Multiple risk factors predict suicide in alcoholism / G.E. Murphy [et al.] // Arch Gen Psychiatry.- 1992.- Vol.49.- P.459-463.
Naltrexone Study Collaboration Group: Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia / I.L. Petrakis [et al.] // Psychopharmacology.- 2004.- Vol.172.- P.291–297.
Nedopil N. Prognosen in der Forensischen Psychiatrie / N. Nedopil // Ein Handbuch fur die Praxis.- Berlin, 2005.- P.16.
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia / T.P. George [et al.] // Am J Psychiatry.- 2000.- Vol.157.- P.1835–1842.
Nissel M. Nicotine dependence, midbrain dopamine systems, and psychiatric disorders / M. Nissel, G.G. Nomikos, T.H. Svensson // Pharmacol Toxicol.- 1995.- Vol.76.- P.157–162.
Nunes E.V. Treatment of Depression in Patients With Alcohol or Other Drug Dependence / E.V. Nunes, F.R. Levin // JAMA.- 2004.- Vol.291.- P.1887-1896.
Nurnberg H.G. A systematic Assessment of the Comorbidity of DSM-IIIR Personality Disorders in alcoholic outpatients / H.G. Nurnberg, A. Rifkin, S. Doddy // The American J of Addictions.- 1999.- Vol.8.- P.136-147.
Personality Disorders in alcoholics and drug adicts / C.A. DeJong [et al.] // Comprehensivt Psychiatry.- 1993.- Vol.34.- P.87-94.
Personality disorders in early adolescence and the development of later substance use disorders in the general population / P. Cohen [et al.] // Drug Alcohol Depend.- 2007.- Vol.88 (Suppl.1).- P.71-84.
Petrakis I.L. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram / I.L. Petrakis, C. Nich, E. Ralevski // Schizophr Bull.- 2006.- Vol.32.- P.644–654.
Powell G. Nature and prevalence of Personality Disorders among patients receiving treatment for alcohol dependence / G. Powell, R. Peveler // J. of Mental Health.- 1996.- Vol.5.- P.305-314.
Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes / B. Buhler [et al.] // Schizophr-Res. – 2002. – Vol.54, № 3. – Р. 243-251.
Prevalence of alcohol and drug abuse in schizophrenic inpatients / M. Soyka [et al.] // European Archives of Psychiatry and Clinical Neurosciences.- 1993.- Vol.242.- P.362-372.
Prevalence of substance misuse in first episode psychosis / R. Cantwell [et al.] // British Journal of Psychiatry.- 1999.-Vol.174.- P.150-153.
Psychopathology in dual diagnosis and non-addicted schizophrenics - are there differences? / M. Soyka [et al.] // Eur-Arch-Psychiatry-Clin-Neurosci. – 2001. – Vol.251, № 5. – P.232-238.
Relationships between symptoms of schizophrenia and substance abuse / M.F. Brunette [et al.] // J-Nerv-Ment-Dis. – 1997. – Vol.185, № 1. – P. 13-20.
Roth R.M. Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism? / R.M. Roth, M.F. Brunette, A.I. Green // Curr Psychiatry Rep.- 2005.- Vol.7.- P.283–291.
Schizophrenia and co-occurring substance use disorder / A.I. Green [et al.] // Am. J. Psychiatry.- 2007.- Vol.164,№3.- P.402-408.
Schukit M.A. Drug and Alcohol Abuse. A clinical guide to diagnosis and treatment / M.A. Schukit.- 3rd ed.- N.Y.; London: Plenum Medical Book Company, 1989.- 307 p.
Schukit M.A. Drug and Alcohol Abuse. A clinical guide to diagnosis and treatment / M.A. Schukit.- 4th ed.- N.Y.; London: Plenum Medical Book Company, 1995.- 307 p.
Smith J. Dangerous dual diagnosis patients / J. Smith, S. Frazer, H. Boer // Hospital and Community Psychiatry.- 1994.-Vol.45.- P.280-281.
Steele C.M. Alcohole myopia: Its prized and dangerous effects / C.M. Steele, R.A. Josephs // American Psychologist.- 1990.- Vol.45.- P.921-933.
Straus M.A. Phisical violence in American families: Risk factors and adaptation to violence in 8,145 families / M.A. Straus, R.J. Gelles.- New Brunswick; N.J.: Transaction,1990.- 287 p.
Substance misuse and psychiatric comorbidity: an overview of the OPCS national psychiatric morbidity survey / M. Farrell [et al.] // Addictive Behaviours.- 1998.-Vol.23.- P.909-918.
Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia / H. Heila [et al.] // Am-J-Psychiatry. – 1997. – Vol.154, №9. - P.1235-1242.
Suicide attempts in major affective disorder patients with comorbid substance use disorders / L. Tondo [et al.] // J Clin Psychiatry.- 1999.- Vol.60(Suppl. 2).- P.63-69.
The Comorbidity of alcoholism and Personality Disorders in a clinical population: prevalence rates and relation to alcohol typology variables / J. Morgenstern [et al.] // J. of Abnormal Psychology.- 1997.- Vol.106.- P.74-84.
The effects of clozapine on alcohol and drug use disorders among schizophrenic patients / R.E. Drake [et al.] // Schizophr Bull.- 2000.- Vol.26.- P.441–449.
The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report / D.A. Smelson [et al.] // J Clin Psychopharmacol.- 2006.- Vol.26.- P.9–12.
The relationship of Axis II Personality Disorders to other known predictors of addiction treatment outcome / H. Pettinati [et al.] // The Fverican J. of Addiction. - 1998.-Vol.22.- P.77-86.
Torgersen S. Epidemiology / S. Torgersen // Textbook of Personality Disorders.- London: Wiley, 2005.- P.129-141.
Use of potentially abusive psychotropic substances in psychiatric inpatients / J. Modestin [et al.] // European Archives of Psychiatry and Clinical Neurosciences.- 1997.- Vol.247.- P.146-153.
Van der Kolk B.A. Traumatic Stress. The effect of Overwhelming Experience on Mind, Body and Society / B.A. Van der Kolk, A.C. McFarlain, L. Weisaeth.- N.Y.; London: Guilford Press, 2007.- 596 p.
Voruganti L.N.P. Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse / L.N.P. Voruganti, R.J. Heslegrave, A.G. Awad // J Nerv Ment Dis.- 1997.- Vol.185.- P.463–465.
Wheatley M. The prevalence and relevance of substance use in detained schizophrenic patients / M. Wheatley // Journal of Forensic Psychiatry.- 1998.-Vol.9.- P.114-129.
Woody G. Dual Diagnosis / G. Woody // NIDA-Pavlov Medical University International Workshop “Pharmacotherapies For Addiction: Basic and Clinical Scienct” (Abstracts/Slides).- St. Peterburg, 2003.
Zimmerman M. DSM-III Personality Disorder Diagnosis in a non-patient sample: demographic correlates and comorbidity / M. Zimmerman, W. Coryell // Arch Gen Psych.- 1989.- Vol.46.- P.682-689.
|
